Table 1 Baseline characteristics of Norwegian patients starting peritoneal- or hemodialysis as initial renal replacement therapy in the period 2005–2012
From: Impact of initial dialysis modality on mortality: a propensity-matched study
All | Unmatched HD | Matched HD | PD | p-values | ||
|---|---|---|---|---|---|---|
(n = 3089) | (n = 2407) | (n = 682) | (n = 682) | PD vs. unmatched HD | PD vs. matched HD | |
Age (years) | 64.8 (15.3) | 64.9 (15.4) | 65.2 (15.0) | 64.6 (15.2) | NS | NS |
Male gender (%) | 67.2 | 67.3 | 67.0 | 66.7 | NS | NS |
County | <0.001 | NS | ||||
Renal diagnosis | <0.001 | NS | ||||
BMI kg/m2 | 25.9 (5.2) | 26.1 (5.5) | 25.5 (5.1) | 25.4 (4.2) | 0.001 | NS |
eGFR ml/min/1.73 m2 | 8.3 (3.2) | 8.2 (3.2) | 9.0 (3.4) | 8.8 (3.1) | <0.001 | NS |
Hb g/dl | 10.6 (1.6) | 10.4 (1.6) | 11.2 (1.5) | 11.3 (1.4) | <0.001 | NS |
Albumin g/l | 34.9 (6.7) | 34.0 (6.7) | 37.8 (5.5) | 38.0 (5.7) | <0.001 | NS |
Prev comorbidities | ||||||
DM (%) | 32.1 | 32.9 | 30.6 | 29.3 | NS | NS |
Heart disease (%) | 31.6 | 33.1 | 30.5 | 26.5 | 0.001 | NS |
LVH (%) | 31.3 | 32.2 | 28.9 | 28.2 | 0.044 | NS |
CVD (%) | 13.9 | 14.5 | 12.0 | 11.9 | NS | NS |
PAD (%) | 20.2 | 21.2 | 18.0 | 16.6 | 0.008 | NS |
Malignancy (%) | 10.0 | 11.3 | 5.4 | 5.7 | <0.001 | NS |
Medications | ||||||
Number of BP medication (%) | <0.001 | NS | ||||
0 | 10.1 | 11.8 | 3.2 | 4.1 | ||
1 | 12.6 | 12.8 | 12.0 | 12.0 | ||
2 | 22.5 | 22.3 | 22.4 | 23.3 | ||
3 | 29.4 | 28.6 | 33.3 | 32.3 | ||
4 | 17.3 | 16.5 | 20.1 | 19.9 | ||
>4 | 8.1 | 8.1 | 8.9 | 8.4 | ||
Statin (%) | 54.0 | 52.3 | 61.1 | 60.3 | 0.001 | NS |
Vitamin D (%) | 59.1 | 55.6 | 70.4 | 71.4 | <0.001 | NS |
ESA (%) | 59.0 | 55.9 | 70.8 | 70.1 | <0.001 | NS |
Known by nephrologist (%) | 74.2 | 69.4 | 91.1 | 91.1 | <0.001 | NS |
RTX candidate (%) | 59.8 | 57.0 | 68.3 | 69.5 | <0.001 | NS |
Follow-up time (months) | 12 (0–92) | 13.0 (0–89) | 10.0 (0–73) | <0.001 | ||